Evidence map›Paper›PMID 35575085›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2022

A Randomized Pilot of a Tailored Smoking Cessation Quitline Intervention for Individuals Who Smoke and Vape.

Katrina A Vickerman, Kelly M Carpenter, Lyndsay N Miles, Johnathan M Hsu, Karen A Watt, Thomas H Brandon, Jonathan T Hart, Harold S Javitz, Theodore L Wagener

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 8 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 8 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Pooled it
  3. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Guideline
  5. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  6. Pooled it
  7. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2024
    Pooled it
  8. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2022
    Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Katrina A VickermanCenter for Wellbeing Research, Optum Health, Eden Prairie, MN, USA.ORCID 0000-0003-3642-5265
Kelly M CarpenterCenter for Wellbeing Research, Optum Health, Eden Prairie, MN, USA.
Lyndsay N MilesCenter for Wellbeing Research, Optum Health, Eden Prairie, MN, USA.
Johnathan M HsuCenter for Wellbeing Research, Optum Health, Eden Prairie, MN, USA.
Karen A WattCenter for Wellbeing Research, Optum Health, Eden Prairie, MN, USA.ORCID 0000-0003-0727-7187
Thomas H BrandonH Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Jonathan T HartTSET Health Promotion Research Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.ORCID 0000-0001-7351-9952
Harold S JavitzSRI International, Menlo Park, CA, USA.
Theodore L WagenerOhio State University Comprehensive Cancer Center, Wexner Medical Center, Columbus, OH, USA.
Optum (United States) · USMoffitt Cancer Center · USSRI International · USThe Ohio State University Wexner Medical Center · USUniversity of Oklahoma Health Sciences Center · US

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ROBERT S. MANNEL · 2018 to 2026
$27.1M
Enhanced E-cigarette Coaching Intervention for Dual Users of Cigarettes and E-cigarettesR21DA042960 · NIDA · CONSUMER WELLNESS SOLUTIONS, INC. · PI VICKERMAN, KATRINA A · 2017 to 2018
$430k
NCI NIH HHS P30 CA225520NIDA NIH HHS R21 DA042960
6 · The paper itself

Abstract

introductionAlthough e-cigarettes are not a federally approved tobacco cessation aid in the United States, many smokers use them to quit or cut down on smoking. Tailored behavioral support could improve rates of complete smoking cessation for those individuals. AIMS AND

methodsA novel behavioral treatment to help dual cigarette and e-cigarette users quit smoking was tested in a randomized pilot with a state tobacco quitline. Ninety-six dual users of cigarettes and e-cigarettes were recruited from incoming state quitline callers and randomized to receive enhanced e-cigarette coaching (EEC) or quitline treatment as usual (TAU) to examine EEC feasibility and acceptability. Outcomes at 3 months were treatment satisfaction, engagement, beliefs, and smoking cessation. This pilot was not powered to detect differences in quit rates.

resultsSixty-nine percent responded to the 3-month survey. EEC treatment satisfaction was noninferior to TAU: 93.8% (30/32) of EEC and 73.5% (25/34) of TAU reported being "very satisfied" or "satisfied" with treatment, respectively. EEC participants completed more coaching calls than TAU (M = 3.4 vs. M = 2.7, p = .03), and the majority in both groups elected to receive nicotine replacement therapy (EEC: 100%, TAU: 94%, p = .24). With missing data imputed as smoking, intent-to-treat 7-day point prevalence smoking abstinence rates were 41.3% (19/46) for EEC and 28.0% (14/50) for TAU (p = .20).

conclusionsThe EEC quitline intervention for dual cigarette and e-cigarette users demonstrated high levels of treatment satisfaction and engagement. This pilot was not powered to detect significant differences in smoking cessation; however, cessation rates were promising and warrant evaluation in a fully powered trial. IMPLICATIONS: If this scalable behavioral treatment to help dual cigarette and e-cigarette users quit smoking proves to be effective in a larger trial, quitlines could implement this harm reduction approach to improve outcomes for callers who already use e-cigarettes and are planning to use them while quitting smoking.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationVapingHumansPilot ProjectsTobacco Use Cessation Devices

Identifiers

PMID35575085
PMCPMC9596999
OpenAlexW4280493367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.